Dabigatran Falsely Elevates Point of Care International Normalized Ratio Results
- 1 September 2011
- journal article
- other
- Published by Elsevier in The American Journal of Medicine
- Vol. 124 (9) , e5-e6
- https://doi.org/10.1016/j.amjmed.2011.02.009
Abstract
No abstract availableThis publication has 2 references indexed in Scilit:
- Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activityThrombosis and Haemostasis, 2010
- Dabigatran versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine, 2009